Serum albumin and FT3/FT4 ratio as additional co-morbidity parameters to predict mortality as a new approach: The Haseki Scoring Index (updated Charlson Comorbidity Index)
<h4>Background</h4> Charlson Comorbidity Index (CCI) is the common and valid method to predict mortality by classifying comorbidities such as cardiovascular, metabolic, renal, hepatic, pulmonary diseases, and malignancy. Novel risk factors are not included in the Charlson Comorbidity Ind...
Main Authors: | Betul Cavusoglu Turker, Fatih Turker, Suleyman Ahbab, Emre Hoca, Meryem Tahmaz, Hayriye Esra Ataoğlu |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920220/?tool=EBI |
Similar Items
-
Serum albumin and FT3/FT4 ratio as additional co-morbidity parameters to predict mortality as a new approach: The Haseki Scoring Index (updated Charlson Comorbidity Index).
by: Betul Cavusoglu Turker, et al.
Published: (2022-01-01) -
Does the FT3-to-FT4 ratio easily predict the progression of NAFLD and NASH cirrhosis?
by: Fatih Türker, et al.
Published: (2021-11-01) -
FT3/FT4 ratio predicts non-alcoholic fatty liver disease independent of metabolic parameters in patients with euthyroidism and hypothyroidism
by: Fatma Yahyaoğlu Gökmen, et al.
Published: (2016-04-01) -
Evaluation of the Charlson Comorbidity Index and Laboratory Parameters as Independent Early Mortality Predictors in Covid 19 Patients
by: Cavuşoğlu Türker B, et al.
Published: (2022-07-01) -
Evaluation of Metabolic Parameters of Gestational Diabetic Patients in Postpartum Period
by: Fatih Türker, et al.
Published: (2018-06-01)